Human immunodeficiency virus type 1 encoded viral protein Vpr is essential for infection of macrophages by HIV-1. Furthermore, these macrophages are resistant to cell death and are viral reservoir. However, the impact of Vpr on the macrophage proteome is yet to be comprehended. The goal of the present study was to use a stable-isotope labeling by amino acids in cell culture (SILAC) coupled with mass spectrometry-based proteomics approach to characterize the Vpr response in macrophages. Cultured human monocytic cells, U937, were differentiated into macrophages and transduced with adenovirus construct harboring the Vpr gene. More than 600 proteins were quantified in SILAC coupled with LC-MS/MS approach, among which 136 were significantly altered upon Vpr overexpression in macrophages. Quantified proteins were selected and clustered by biological functions, pathway and network analysis using Ingenuity computational pathway analysis. The proteomic data illustrating increase in abundance of enzymes in the glycolytic pathway (pentose phosphate and pyruvate metabolism) was further validated by western blot analysis. In addition, the proteomic data demonstrate down regulation of some key mitochondrial enzymes such as glutamate dehydrogenase 2 (GLUD2), adenylate kinase 2 (AK2) and transketolase (TKT). Based on these observations we postulate that HIV-1 hijacks the macrophage glucose metabolism pathway via the Vpr-hypoxia inducible factor 1 alpha (HIF-1 alpha) axis to induce expression of hexokinase (HK), glucose-6-phosphate dehyrogenase (G6PD) and pyruvate kinase muscle type 2 (PKM2) that facilitates viral replication and biogenesis, and long-term survival of macrophages. Furthermore, dysregulation of mitochondrial glutamate metabolism in macrophages can contribute to neurodegeneration via neuroexcitotoxic mechanisms in the context of NeuroAIDS.
Citation: Barrero CA, Datta PK, Sen S, Deshmane S, Amini S, Khalili K, et al. (2013) HIV-1 Vpr Modulates Macrophage Metabolic Pathways: A SILAC-Based Quantitative Analysis. PLoS ONE 8(7): e68376. https://doi.org/10.1371/journal.pone.0068376
Editor: Richard Y. Zhao, Institute of Human Virology, Baltimore, United States of America
Received: March 10, 2013; Accepted: May 29, 2013; Published: July 12, 2013
Copyright: © 2013 Barrero et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work is supported in part by funding from the National Institutes of Health (NIH) (PKD: NIH/NIDA 5 R01 DA033213-02; SA: P01NS4390; KK: P30MH092177; RO1MH092371 and RO1MH086358). This study utilized services offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC, NIMH grant number P30MH092177) at Temple University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: Prasun K. Datta is a PLOS ONE Editorial Board member. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) is a small 96-amino acid multifunctional protein –. Vpr is essential for HIV-1 infection of macrophages since virus deficient in Vpr is less efficient in replication in macrophages . Furthermore, extracellular Vpr can rescue replication of Vpr-deficient HIV strains in macrophages . HIV-1 LTR activation by Vpr results in increased viral replication , . Vpr-mediated transcriptional induction of HIV-1 involves interaction between Vpr with specific sequences that span the C/EBP and adjacent NFκB sites of HIV-1 LTR , and transcription factor, Sp1 , . Vpr induces apoptosis in several cell types, including lymphocytes, monocytes, astrocytes, and neurons –. However, HIV-1 infected macrophages are resistant to apoptosis . These observations suggest that Vpr modulates macrophage proteome to promote viral replication and induce anti-apoptotic pathways. This acquired anti-apoptotic phenotype may promote reservoir formation in this cell type. Therefore, analysis of the macrophage proteome in Vpr expressing macrophages can help to better understand mechanisms involved in HIV-1 replication and survival.
A variety of stable-isotope labeling strategies, such as isotope-coded affinity tag (ICAT), isobaric tags for relative and absolute quantitation (iTRAQ) and stable-isotope labeling by amino acids in cell culture (SILAC) coupled with mass spectrometry (MS)-based proteomics allows reliable identification and quantitative analysis of multiple proteins in complex samples –. We used SILAC, as a metabolic labeling method, since it is simple, efficient, and allows for almost complete heavy isotope incorporation in cells , . To explore novel mechanisms underlying Vpr-mediated modulation of macrophage proteome, we employed LC-MS/MS, along with SILAC to assess quantitatively Vpr-induced perturbation of protein expression in U937 derived macrophages.
More than 600 proteins were quantified in SILAC coupled with LC-MS/MS measurement, among which 136 were significantly altered upon Vpr overexpression in macrophages. Importantly, we observed, for the first time, that Vpr-induced up-regulation of enzymes in the pyruvate metabolism, pentose phosphate pathway, and mitochondrial dysfunction.
Materials and Methods
The human monocytic cell line U937 was obtained from American Type Culture Collection (Manassas, VA).
Chemicals and Antibodies
Heavy lysine and arginine ([13C6, 15N2]-L-lysine and [13C6]-L-arginine) were obtained from Cambridge Isotope (Andover, MA) and light amino acids (L-lysine and L-arginine) were obtained from Sigma-Aldrich (St. Louis, MO). All components of cell culture media were obtained from Life Technologies (CA) and protease inhibitor cocktail was obtained from Sigma-Aldrich (St, Louis, MO). SILAC DMEM Media was obtained from Pierce Biotechnology and the dialyzed FBS was purchased from HyClone (Logan, UT). Trypsin was purchased from Promega (Madison, WI). All the chemicals were HPLC-grade unless specifically mentioned. The antibodies against HK-1, HK-2, G6PD, PKM2 and Grb2 were obtained from Cell Signaling Technology (Danvers, MA); HIF-1 alpha antibody was obtained from BD Biosciences (San Jose, CA).
U937 cells were cultured in RPMI containing 10% FBS supplement with penicillin and streptomycin at 37°C in humidified atmosphere with 5% CO2.
Construction of Recombinant Adenoviruses
To construct recombinant adenoviral vector harboring HIV-1 Vpr, Vpr cDNA from the dual-tropic (CCR5 and CXCR4) strain of HIV-1 89.6  was used. Vpr cDNA (288 bp) was excised from pcDNA3-Vpr and cloned into the EcoRI and NheI sites of the adenovirus-shuttle plasmid pDC515 under the control of the murine cytomegalovirus promoter (purchased from Microbix Inc., Ontario, Canada). Adeno-Vpr recombinant shuttle containing Vpr sequence (pDC515-Vpr) was transfected into HEK-293 cells with pBHGfrt (del) E1, 3FLP, and a plasmid that provides adenovirus type 5 genome deleted in E1 and E3 genes. Plaques of recombinant adenovirus arising as a result of frt/FLP recombination were isolated, grown, and purified by cesium chloride density equilibrium banding. Empty shuttle plasmid, pDC515, was used to construct control adenoviral vector (Adeno-null, a virus without a transgene).
Differentiation of U937 Cells into Macrophages and Culture in SILAC Media
SILAC DMEM media was supplemented with 10% dialyzed fetal bovine serum, 1% streptomycin/penicillin. The medium was then divided and supplemented with 13C6 L-arginine and 13C6, 15N2-L-lysine or normal L-arginine and L-lysine, to produce heavy or light SILAC medium, respectively. U937 cells were treated with 100 ng/ml of phorbal myristate acetate (PMA) for 3 hrs in complete RPMI medium at 37°C and then washed with 1XPBS and cultured for an additional 24 h in complete RPMI medium at 37°C. For SILAC experiments, the PMA differentiated cells were then grown in parallel in either light or heavy media for 5 days, with media replacement every 24 h.
Transduction of SILAC Labeled Cells with Adenoviral Constructs
The PMA differentiated cells (macrophages) grown in SILAC media were then transduced with adenoviral stock corresponding to a multiplicity of infection (MOI) of five plaque-forming units per cell. The heavy labeled cells were transduced with Adeno-Vpr, while the light-labeled cells were transduced with Adeno-Null. The cells were harvested at 72 h post infection.
Preparation of Protein Samples, 1-D SDS-PAGE Separation and In-gel Trypsin Digestion
Proteins were processed for gel electrophoresis-liquid chromatography-mass spectroscopy (GeLC-MS/MS) proteomics analysis. Total cell proteins were extracted from cells transduced with Adeno-Vpr and control cells using RIPA buffer (25 mM Tris•HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS). Protein quantification was performed using the method of Bradford (Bio-Rad Protein Assay). 60 µg of total proteins (30 µg “heavy” and 30 µg “light”) were diluted with Laemmli sample buffer (Bio-Rad) containing 5% β-mercaptoethanol. The mixture was heated for 5 min at 90°C and loaded onto 10% polyacrylamide gel. 1-D SDS-PAGE separation was performed using a mini Protean II system (BioRad) at 200 V for 45 min. Bands were visualized with Simply Blue Safe Stain and lanes were sliced into 11 sections, which were diced into ∼ 1×1 mm. After distaining with 50% v/v Acetonitrile (ACN) in 25 mM ammonium bicarbonate buffer (bicarbonate buffer), proteins within gel pieces were reduced with 10 mM DTT in bicarbonate buffer and alkylated by incubation with 50 mM iodoacetamide in bicarbonate buffer. After gel dehydration with 100% ACN, the gel pieces were covered with approximately 40 µL of 12.5 µg/mL trypsin in bicarbonate buffer. In gel digestion was done at 37°C for 12 h, trypsin was inactivated with formic acid at 2% final volume and peptides were extracted and clean-up using C18 Tip column (ZipTips®) as previously described .
GeLC-MS/MS and Data Analysis
Peptides were dried in a vacuum centrifuge then resuspended in 30 µL of 0.1% v/v TFA/H2O. Peptide samples were loaded onto 2 µg capacity peptide traps (CapTrap; Michrom Bio-resources) and separated using a C18 capillary column (15 cm 75 mm, Agilent) with an Agilent 1100 LC pump delivering mobile phase at 300 nL/min. Gradient elution using mobile phases A (1% ACN/0.1% formic acid, balance H2O) and B (80% ACN/0.1% formic acid, balance H2O) was as follows (percentages for B, balance A): linear from 0 to 15% at 10 min, linear to 60% at 60 min, linear to 100% at 65 min. The nano ESI MS/MS was performed using a HCT Ultra ion trap mass spectrometer (Bruker). ESI was delivered using distal-coating spray Silica tip (id 20 µm, tip inner id 10 µm, New Objective, Ringoes, NJ). Mass spectra were acquired in positive ion mode, capillary voltage at −1200 V and active ion charge control trap scanning from 300 to 1500 m/z; Using an automatic switching between MS and MS/MS modes, MS/MS fragmentation was performed on the two most abundant ions on each spectrum using collision-induced dissociation with active exclusion (excluded after two spectra, and released after 2 min). The complete system was fully controlled by HyStar 3.2 software.
Mass spectra data processing was performed using Mascot Distiller (Version 126.96.36.199) with search and quantitation toolbox options. The generated de-isotoped peak list was submitted to an in-house Mascot server 2.4.0 for searching against the SwissProt database version 2013_01 (538849 sequences; 191337357 residues). Mascot search parameters were set as follows: species, Homo sapiens (20,233 sequences); enzyme, trypsin with maximal 2 missed cleavage; fixed modification: cysteine carbamidomethylation; variable modifications: methionine oxidation, Gln->pyro-Glu (N-term Q), Glu->pyro-Glu (N-term E), Label:13C(6)15N(2) (K), Label:13C(6) (R); 0.90 Da mass tolerance for precursor peptide ions; and 0.6 Da for MS/MS fragment ions. SILAC quantitation was performed in Mascot Distiller using SILAC K+8 R+6 quantitation method, SILAC ratios for heavy and light peptide pairs were calculated by Simpsons integration method, minimum 1 peptide with unique sequence and 0.05 of significant threshold. The following criteria were used to evaluate protein identification: one or more unique peptides with ion score ≥45 and two or more unique peptides with ion score ≥30 (p≤0.05 threshold); proteins identified were extracted using MS Data Miner (MDM) . Quantified proteins with ≥1.5 and ≤0.7 fold change were selected and clustered by biological functions, pathway and network analysis using Ingenuity computational pathway analysis (IPA) software (www.ingenuity.com) for bioinformatics analysis.
Western Blot Analysis
Protein samples (40 µg) were separated by 10% gradient SDS-PAGE and then transferred to a nitrocellulose membrane in a blotting chamber (BioRad) at 100 V for 30 min. The membrane was blocked with 5% powdered milk in Tris-buffer saline solution (pH 7.6) containing 0.05% Tween-20 (TBS/T) then probed with antibodies against (PKM2, HK-1, HK-2, G6PD, HIF-1α and Vpr) diluted 1∶500. Membranes were incubated with primary antibodies overnight at 4°C, washed, and then incubated with appropriate HRP-conjugated secondary antibodies at room temperature for 1 h. ECL Plus kit (GE healthcare) for HRP was used according to the manufacturer’s instructions and signals were captured onto X-ray film.
Statistics for IPA analysis can be found at http://www.ingenuity.com/index/html. For western blot analysis Student’s t-test was used for statistical analysis and p ≤ 0.05 was considered statistically significant.
Proteome of Vpr Transduced Macrophages
To get a global perspective of the molecular pathways perturbed by Vpr in macrophages, we employed SILAC in conjunction with LC-MS/MS to assess Vpr-induced differential expression of the whole proteome of U937 derived macrophages (Figure 1).
PMA differentiated U937 cells cultured in light or heavy media and then transduced with Adeno-Null or Adeno-Vpr virus, respectively. Protein lysates were prepared and mixed in 1∶1 ratio. Sample complexity was reduced prior to LC-MS/MS analysis by fractionation at the protein level by SDS-PAGE. Expression levels of selected proteins were validated by western blot analysis.
In this study, PMA differentiated U937 macrophages were cultured in both light and heavy media. The light labeled cells were transduced with Adeno-Null virus and the heavy labeled cells were transduced with Adeno-Vpr. Cell pellets prepared 72 h post transduction were lysed, and the lysates were combined and subsequently fractionated by SDS-PAGE. After in-gel digestion, the proteins were identified and quantified by LC-MS/MS. This analysis was performed once and a total of 614 proteins were identified and quantified. Details of all quantified proteins can be found in File S1).
For quantitative analysis of differences between paired experimental samples we chose a ratio of ≥1.5 or ≤0.7 as threshold for screening significantly changed proteins. Using this criterion we identified a total of 136 proteins that displayed significant changes in Vpr expressing macrophages, among which 67 and 69 were up- and down- regulated, respectively as shown in the differential protein expression list (Sup. info. 1).
Functional Characterization of Identified Proteins and Bioinformatics Analysis
We next used the 136 differentially expressed proteins identified in response to Vpr over expression, to perform a biological function, pathway and network analysis using the Ingenuity Pathway Analysis (IPA) software. According to the molecular function analysis (Figure 2), most of the proteins were related with metabolic pathways (39%), protein metabolism (17%), cell cycle regulation (15%), signal transduction (12%), phagosomal activity (10%), membrane trafficking (10%), gene expression (8%), RNA metabolism (8%), cell cycle (6%), extracellular matrix organization (6%), signal transduction (5%), cell adhesion molecules (4%) and unclassified (22%).
The pie graph demonstrates that among the 136 differentially expressed proteins majority of them cluster in the metabolic pathways and metabolism of proteins.
The list of the proteins that were altered and are related with metabolic pathway is listed in Table 1 (also listed in File S2). The canonical pathways that were identified at statistically significant levels (p≤0.05) are depicted in Figure 3, highlighted are the TCA cycle, glycolysis, NRF2 mediated oxidative stress response and mitochondrial dysfunction. The other pathways that were identified at statistically significant levels (p≤0.05) include virus entry via endocytic pathway, viral exit from host cells, fatty acid beta-oxidation, HIF-1 alpha signaling and others (Figure 3; also see File S2). The scores (-log [p values]) reflect the probabilities of such associations occurring by chance, with the threshold value for significance set at 1.25.
Graph represents host cell functions with highest score (y-axis) based on the number of differentially regulated proteins.
Proteins that changed significantly in Vpr expressing macrophages were mapped to 6 specific functional networks, with each network containing 13 or more “focus” members (Table 2). The top three networks of interest correspond to (1) organ morphology, nucleic acid metabolism, small molecule biochemistry (score = 49), (2) carbohydrate metabolism, energy production, nucleic acid metabolism (score = 41), and (3) nucleic acid metabolism, small molecule biochemistry, DNA replication, recombination, and repair (score = 33). Figure 4A and B shows the “interactomes” of the top 2 (out of 9 significant scoring, Sup. Info 2) local connecting networks and functional associations within those networks.
Two relevant networks were generated from the Vpr-modulated proteins according to the Ingenuity Pathway Knowledge Criteria. A. Organ morphology, nucleic acid metabolism, small molecule biochemistry (score = 49). B. Carbohydrate metabolism, energy production, nucleic acid metabolism (score = 41). Red, up-regulated proteins; green, significantly down-regulated proteins; white, proteins known to be in the network but were not identified or identified in our study. The color depth indicates the magnitude of the change in protein expression level. The shapes are indicative of the molecular class (i.e., protein family). Lines connecting the molecules indicate molecular relationships. Dashed lines indicate indirect interactions, and solid lines indicate direct interactions. The arrow styles indicate specific molecular relationships and the directionality of the interaction.
Validation of Protein Identification and Quantification
Since the functional characterization and bioinformatics analysis revealed that the pathways that were significantly altered involved glycolysis, mitochondrial dysfunction, and HIF-1α signaling, we therefore focused on the validation of relative abundance of some of the proteins in these pathways by western blot analysis. The western blot analysis demonstrates that the changes in the ratios of representative proteins (HK-1, HK-2, PKM2, G6PD), between adeno-null transduced and adeno-Vpr transduced macrophages (Figure 5A and B) are consistent with that derived from SILAC studies. In tune with our earlier observation that Vpr induces HIF-1 alpha  we have observed a significant increase in HIF-1 alpha levels in Vpr transduced macrophages. In contrast, Figure 5A, shows data for Grb2 (Growth factor receptor-binding protein 2) protein remained unchanged between null and Vpr transduced cells. Taken together, these data indicate that the SILAC strategy can efficiently detect specific protein alterations in macrophages that overexpress HIV-1 Vpr.
A. Western blot analysis of protein lysates prepared from macrophages derived from U973 cells transduced with Adeno-Null or Adeno-Vpr virus. Molecular weight of respective protein is shown in kDa. B. Densitometric analyses of the representative proteins were done after normalization to Grb2 levels. Values represent means ± S.E of three experiments. *indicate p value<0.05, #indicate p value>0.05 or not significant.
Over the last few years, proteomics has contributed significantly in HIV research to investigate not only HIV pathogenesis but also for identification of potential biomarkers –. In this study, we utilized the high-throughput quantitative proteomic approach using SILAC to obtain information about the macrophage proteome in the context of Vpr-host interaction since Vpr from strain 89.6 demonstrates PP2A-dependent apoptosis in CD4+ T cells and Vpr gene polymorphism is known to influence clinical outcomes , . A total of 136 different proteins were identified as having altered abundances in Vpr transduced macrophages, including those involved in pyruvate metabolism, pentose phosphate pathway, mitochondrial dysfunction, oxidative stress, HIF-1 alpha signaling, and cell cycle: G2/M DNA damage checkpoint regulation. Previous reports have demonstrated the effects of HIV-1 on metabolic and neurological pathways at the level of transcriptome in diverse cell types including the brain –. Our proteomics data are in concordance with the transcriptome analysis that also demonstrated the interference of HIV-1 in host energy metabolism pathways , .
In this study we have found increased expression of numerous enzymes involved in glycolytic and citrate pathways viz., Hexokinase (HK), Glucose-6-phosphate dehydrogenase (G6PD), pyruvate kinase M2 (PKM2), and Fumarate hydratase (Fumarase).
HK is the rate-limiting enzyme that converts glucose in to glucose-6-phosphate (G6P), while G6PD a member of the pentose phosphate pathway (PPP) is involved in the conversion to G6P to 6PG . Furthermore, upregulation of hexokinase expression and shunting of glucose through the pentose phosphate pathway (PPP) creates a restrictive environment for cytochrome c-mediated apoptosis as a result of increased translocation of HK to outer mitochondrial membrane (OMM), and generation of NADPH, respectively (Figure 6) , . Cellular redox status is maintained by scavenging ROS by glutathione whose synthesis is regulated by NADPH . In addition, upregulation of PPP and activation of G6PD also promotes nucleotide biosynthesis that provides the nucleotide pool  required for sustained HIV-1 replication (Figure 6).
HIV-1 Vpr induces HIF-1α that in turn induces HK and PKM2. Upregulation of HK expression on one hand results in conversion of glucose into glucose-6-phosphate (G6P) and forward feed into phosphoenolpyruvate (PEP) for conversion into pyruvate by PKM2 which then enters into mitochondria for conversion into Acetyl-CoA via the TCA cycle. On the other hand, HK can translocate to the outer mitochondrial membrane to confer an anti-apoptotic phenotype. Glucose, in addition can be metabolized by upregulation of Glucose-6-phosphate dehydrogenase (G6PD) via the pentose-phosphate pathway (PPP). In this pathway glucose-6-phosphate is decarboxylated to form ribose-5-phosphate (R5P) in a series of reaction involving 6-phosphogluconate dehydrogenase (6PGD) for the synthesis of nucleotides. The pentose phosphate pathway also reduces NADP+ to NADPH (H+), a cofactor necessary for antioxidant glutathione (GSH) regeneration from its disulfide form (GSSG) for attenuation of oxidative stress. Nuclear translocation of PKM2 can lead to Stat3 phosphorylation and activation of HIV-1 LTR.
PKM2 acts as a glycolytic enzyme, transferring a phosphate group from phosphoenolpyruvate (PEP) to ADP to yield one molecule of pyruvate and one molecule of ATP . Earlier studies from our laboratory have demonstrated the role of oxidative stress in Vpr mediated regulation of HIF-1 alpha . Interestingly, HIF-1 alpha not only induces PKM2 expression but also other enzymes involved in glucose metabolism . Earlier studies have demonstrated upregulation of PKM2 in HIV-1 infected macrophages and in HIV-1 infected human astrocytes treated with cocaine ,  however, its role in HIV-1 LTR activation remains unknown. Recent studies demonstrate that PKM2 has non metabolic functions and plays significant role in regulating gene transcription , .
PKM2 is apparently a dual-specificity protein kinase since it phosphorylates Stat3 at Y705 and histone H3 at T11 , . Furthermore, phosphorylation of H3-T11 by PKM2 leads to the induction of Myc gene transcription following dissociation of HDAC3 . Interestingly, HDAC3 inhibition leads activation of latent HIV-1 . HIV-1 (BaL) and HIV-1 (LAI) are known to selectively induce phosphorylation of Stat3, and repression of Stat3 expression inhibits HIV-1 replication . Based on these observations, it can be proposed that Vpr mediated PKM2 up regulation might play a role in Stat3 mediated HIV-1 LTR activation or HDAC3 dissociation from HIV-1 LTR in HIV-1 latency. Future studies are to be undertaken to elucidate the proposed mechanism.
Fumarate hydratase (Fumarase) is member of the tricarboxylic acid (TCA) cycle in mitochondria and converts fumarate to malate . The cytosolic isoform of fumarase plays a role in DNA repair by translocating from the cytoplasm to nucleus .
The upregulation of PKM2, G6PD and fumarate hydratase in our study are in tune with an earlier study that demonstrated increased levels of pyruvate, NADPH and malate in the metabolite pool of activated U1 cells (HIV-1 infected U937 cells) by LC-MS/MS analysis . Interestingly, some of the other proteins that are upregulated are transferrin receptor-1 (TfR1), hypoxia up-regulated protein 1 (HYOU1) also known as oxygen-regulated protein 150 (ORP-150), USO1 vesicle docking protein homolog (USO1), matrin 3, and glutathione S-transferase Pi 1. Among these proteins upregulation of HYOU1 and USO1 was demonstrated in HIV-1 infected CD4+T cells .
TfR1 is a cell membrane-associated glycoprotein responsible for incorporation of the iron bound to transferrin through an endocytotic process from the circulating blood . Interestingly, TfR1 is upregulated by HIF-1 activation . HYOU1/ORP-150 belongs to heat shock protein 70 family and plays an important role in protein folding and secretion in the ER , . Suppression of HYOU1/ORP150 expression leads to accelerated apoptosis . Physical interaction between HIV-1 gp120 and HYOU1 was observed in human HEK293 and/or Jurkat cell lines by using affinity tagging and purification mass spectrometry analyses . USO1 also known as Golgi complex-associated protein p115 is known to play a critical role in the regulated secretion of macrophage migration inhibitory factor (MIF) from monocytes/macrophages . Matrin 3 has been shown to bind Rev/RRE-containing viral RNA and stabilize unspliced and partially spliced HIV-1 transcripts that subsequently results in increased cytoplasmic expression of these viral RNAs . Glutathione S-transferases (GST) are involved in cellular protection against oxidative stress. Transcriptional induction of GSTP1 has been shown to be a part of an adaptive response to oxidative stress , and also to protect 3T3 mouse fibroblasts against H2O2 mediated oxidative stress  and is postulated to be involved in signaling during oxidative stress.
Among the proteins whose expression is down regulated in Vpr transduced macrophages are Glutamate dehydrogenase 2 (GLUD2), Adenylate kinase 2 (AK2) and Transketolase (TKT). GLUD2 is a mitochondrial enzyme involved in glutamate metabolism it catalyzes the reversible oxidative deamination of glutamate to alpha-ketoglutarate . Dysregulation of glutamate metabolism in macrophages therefore can contribute to neurodegeneration via neuroexcitotoxic mechanisms in the context of NeuroAIDS. AK2 is a mitochondrial enzyme that regulates adenine nucleotide interconversion . AK2 is known to mediate mitochondrial apoptosis through the formation of an AK2-FADD-caspase-10 (AFAC10) complex . Thus, down regulation of AK2 by Vpr might play an anti-apoptotic role in macrophages. TKT is a thiamine-dependent enzyme that plays a role in the channeling of excess sugar phosphates to glycolysis in the pentose phosphate pathway .
We have used a SILAC-based proteomic approach to investigate alteration in the macrophage proteome by HIV-1 protein Vpr. Our studies demonstrate how a single viral protein as opposed to the whole virus has comparable impact and underscores the role of Vpr in modulating changes at the transcriptome and proteome level in HIV-1 infected host. It would be interesting to further investigate the role of the identified proteins, specifically PKM2 in HIV-1 replication, and HK and G6PD in anti-apoptotic pathways in macrophages. We postulate that HIV-1 hijacks the macrophage glucose metabolism pathway via the Vpr-HIF-1 alpha axis to create an environment that is not only advantageous for viral replication and biogenesis, but also for long-term survival of infected macrophages (Figure 6). We anticipate that the information obtained from this and future studies would enhance our understanding of the role of Vpr in HIV-1 replication and may help formulate novel therapeutic approaches that targets glucose metabolism to mitigate HIV replication and survival in macrophages.
Conceived and designed the experiments: PKD SA KK SM. Performed the experiments: CAB PKD SS SD SM. Analyzed the data: CAB PKD SS SD SA KK SM. Contributed reagents/materials/analysis tools: CAB PKD SS SD SA KK SM. Wrote the paper: PKD KK SM.
- 1. Amini S, Khalili K, Sawaya BE (2004) Effect of HIV-1 Vpr on cell cycle regulators. DNA Cell Biol 23: 249–260.
- 2. Le Rouzic E, Benichou S (2005) The Vpr protein from HIV-1: distinct roles along the viral life cycle. Retrovirology 2: 11.
- 3. Planelles V, Benichou S (2009) Vpr and its interactions with cellular proteins. Curr Top Microbiol Immunol 339: 177–200.
- 4. Kogan M, Rappaport J (2011) HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology 8: 25.
- 5. Zhao RY, Li G, Bukrinsky MI (2011) Vpr-host interactions during HIV-1 viral life cycle. J Neuroimmune Pharmacol 62: 216–229.
- 6. Sharifi HJ, Furuya AM, de Noronha CM (2012) The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest. Curr Opin HIV AIDS 7: 187–194.
- 7. Connor RI, Chen BK, Choe S, Landau NR (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995 206: 935–944.
- 8. Eckstein DA, Sherman MP, Penn ML, Chin PS, De Noronha CM, et al. (2001) HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. J Exp Med 194: 1407–1419.
- 9. Subbramanian RA, Kessous-Elbaz A, Lodge R, Forget J, Yao XJ, et al. (1998) Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J Exp Med 187: 1103–1111.
- 10. Jacquot G, Le Rouzic E, David A, Mazzolini J, Bouchet J, et al. (2007) Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. Retrovirology 4: 84.
- 11. Burdo TH, Nonnemacher M, Irish BP, Choi CH, Krebs FC, et al. (2004) High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate withHIV-1-associated dementia. DNA Cell Biol 23: 261–269.
- 12. Wang L, Mukherjee S, Jia F, Narayan O, Zhao LJ (1995) Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem 270: 25564–25569.
- 13. Sawaya BE, Khalili K, Mercer WE, Denisova L, Amini S (1998) Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J Biol Chem 273: 20052–20057.
- 14. Muthumani K, Hwang DS, Desai BM, Zhang D, Dayes N, et al. (2002) HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J Biol Chem 277: 37820–37831.
- 15. Arokium H, Kamata M, Chen I (2009) Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells. J Virol 83: 11283–11297.
- 16. Saxena M, Busca A, Pandey S, Kryworuchko M, Kumar A (2011) CpG protects human monocytic cells against HIV-Vpr-induced apoptosis by cellular inhibitor of apoptosis-2 through the calcium-activated JNK pathway in a TLR9-independent manner. J Immunol 187: 5865–5878.
- 17. Patel CA, Mukhtar M, Pomerantz RJ (2000) Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J Virol 74: 9717–9726.
- 18. Mukerjee R, Chang JR, Del Valle L, Bagashev A, Gayed MM, et al. (2011) Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem 286: 34976–34985.
- 19. Godet AN, Guergnon J, Croset A, Cayla X, Falanga PB, et al. (2010) PP2A1 binding, cell transducing and apoptotic properties of Vpr(77–92): a new functional domain of HIV-1 Vpr proteins. PLoS One 5: e13760.
- 20. Busca A, Saxena M, Kumar A (2012) Critical role for antiapoptotic Bcl-xL and Mcl-1in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis. J Biol Chem 287: 15118–15133.
- 21. Smolka MB, Zhou H, Purkayastha S, Aebersold R (2001) Optimization of the isotope-coded affinity tag-labeling procedure for quantitative proteome analysis. Anal Biochem 297: 25–31.
- 22. Zieske LR (2006) A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot 57: 1501–1508.
- 23. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, et al. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376–386.
- 24. Duan X, Kelsen SG, Clarkson AB Jr R, Merali S (2010) SILAC analysis of oxidative stress-mediated proteins in human pneumocytes: new role for treacle. Proteomics 10: 2165–2174.
- 25. Collman R, Balliet JW, Gregory SA, Friedman H, Kolson DL, et al. (1992) An unusual macrophage-trophic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 66: 7517–7521.
- 26. Dyrlund TF, Poulsen ET, Scavenius C, Sanggaard KW, Enghild JJ (2012) MS Data Miner: A web-based software tool to analyze, compare and share mass spectrometry protein identifications. Proteomics 12: 2792–2796.
- 27. Deshmane SL, Mukerjee R, Fan S, Del Valle L, Michiels C, et al. (2009) Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem 284: 11364–11373.
- 28. Navare AT, Sova P, Purdy DE, Weiss JM, Wolf-Yadlin A, et al. (2012) Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation. Virology 429: 37–46.
- 29. Meléndez LM, Colon K, Rivera L, Rodriguez-Franco E, Toro-Nieves D (2011) Proteomic analysis of HIV-infected macrophages. J Neuroimmune Pharmacol 6: 89–106.
- 30. Wiederin J, Rozek W, Duan F, Ciborowski P (2009) Biomarkers of HIV-1 associated dementia: proteomic investigation of sera. Proteome Sci. 7: 8.
- 31. Pendyala G, Trauger SA, Kalisiak E, Ellis RJ, Siuzdak G, et al. (2009) Cerebrospinalfluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys. J Proteome Res 8: 2253–2260.
- 32. Toro-Nieves DM, Rodriguez Y, Plaud M, Ciborowski P, Duan F, et al. (2009) Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment. J Neurovirol 15: 36–50.
- 33. Wang T, Gong N, Liu J, Kadiu I, Kraft-Terry SD, et al. (2008) Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk. PLoS One 3: e2507.
- 34. Ringrose JH, Jeeninga RE, Berkhout B, Speijer D (2008) Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J Virol 82: 4320–4330.
- 35. Ricardo-Dukelow M, Kadiu I, Rozek W, Schlautman J, Persidsky Y, et al. (2007) HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J Neuroimmunol 185: 37–46.
- 36. Chen X, Zheng Y, Li H, Mamadou D, Zhang C, et al. (2011) The Vpr gene polymorphism of human immunodeficiency virus type 1 in China and its clinical significance. Curr HIV Res 9: 295–299.
- 37. Wu JQ, Dyer WB, Chrisp J, Belov L, Wang B, et al. (2008) Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy. Retrovirology 5: 24.
- 38. Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, et al. (2008) Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses. Virology 380: 124–135.
- 39. Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, et al. (2011) Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease. Retrovirology 8: 18.
- 40. Wu JQ, Sassé TR, Wolkenstein G, Conceicao V, Saksena MM, et al. (2013) Transcriptome analysis of primary monocytes shows global down-regulation of genetic networks in HIV viremic patients versus long-term non-progressors. Virology 435: 308–319.
- 41. Zhou L, Pupo GM, Gupta P, Liu B, Tran SL, et al. (2012) A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration. BMC Genomics 13: 677.
- 42. Marín-Hernández A, Gallardo-Pérez JC, Rodríguez-Enríquez S, Encalada R, Moreno-Sánchez R, et al. (2011) Modeling cancer glycolysis. Biochim Biophys Acta 1807: 755–767.
- 43. Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V (2004) In self-defense: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem J 377: 347–355.
- 44. Stanton RC (2012) Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 64: 362–369.
- 45. Cosentino C, Grieco D, Costanzo V (2011) ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 30: 546–555.
- 46. Luo W, Hu H, Chang R, Zhong J, Knabel M, et al. (2011) Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145: 732–744.
- 47. Reynolds JL, Mahajan SD, Bindukumar B, Sykes D, Schwartz SA, et al. (2006) Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res 1123: 226–236.
- 48. Rivera-Rivera L, Perez-Laspiur J, Colón K, Meléndez LM (2012) Inhibition of interferon response by cystatin B: implication in HIV replication of macrophage reservoirs. J Neurovirol 18: 20–29.
- 49. Gao X, Wang H, Yang JJ, Liu X, Liu ZR (2012) Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 45: 598–609.
- 50. Yang W, Xia Y, Hawke D, Li X, Liang J, et al. (2012) PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 150: 685–696.
- 51. Huber K, Doyon G, Plaks J, Fyne E, Mellors JW, et al. (2011) Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells. J Biol Chem 286: 22211–22218.
- 52. Tjernlund A, Walther-Jallow L, Behbahani H, Screpanti V, Nowak P, et al. (2007) Leukemia inhibitor factor (LIF) inhibits HIV-1 replication via restriction of stat 3 activation. AIDS Res Hum Retroviruses 23: 398–406.
- 53. Raimundo N, Baysal BE, Shadel GS (2011) Revisiting the TCA cycle: signaling to tumor formation. Trends Mol Med 17: 641–649.
- 54. Yogev O, Yogev O, Singer E, Shaulian E, Goldberg M, et al. (2010) Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol 8: e1000328.
- 55. Hollenbaugh JA, Munger J, Kim B (2011) Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis. Virology 415: 153–159.
- 56. Sargent PJ, Farnaud S, Evans RW (2005) Structure/function overview of proteins involved in iron storage and transport. Curr Med Chem 12: 2683–2693.
- 57. Tacchini L, Gammella E, De Ponti C, Recalcati S, Cairo G (2008) Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. J Biol Chem 283: 20674–20686.
- 58. Takeuchi S (2006) Molecular cloning, sequence, function and structural basis of human heart 150 kDa oxygen-regulated protein, an ER chaperone. Protein J 25: 517–528.
- 59. Ni M, Lee AS (2007) ER chaperones in mammalian development and human diseases. FEBS Lett 581: 3641–3651.
- 60. Cechowska-Pasko M, Bankowski E, Chene P (2006) The effect of hypoxia on the expression of 150 kDa oxygen-regulated protein (ORP 150) in HeLa cells. Cell Physiol Biochem 17: 89–96.
- 61. Jäger S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, et al. (2011) Global landscape of HIV-human protein complexes. Nature 481: 365–370.
- 62. Merk M, Baugh J, Zierow S, Leng L, Pal U, et al. (2009) The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor. J Immunol 182: 6896–6906.
- 63. Yedavalli VS, Jeang KT (2011) Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression. Retrovirology 20 8: 61.
- 64. Hayes JD, Pulford DJ (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445–600.
- 65. Yin Z, Ivanov VN, Habelhah H, Tew K, Ronai Z (2000) Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases Cancer Research. 60: 4053–4057.
- 66. Plaitakis A, Latsoudis H, Spanaki C (2011) The human GLUD2 glutamate dehydrogenase and its regulation in health and disease. Neurochem Int 59: 495–509.
- 67. Noma T (2005) Dynamics of nucleotide metabolism as a supporter of life phenomena. J Med Invest 52: 127–136.
- 68. Lee HJ, Pyo JO, Oh Y, Kim HJ, Hong SH, et al. (2007) AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat Cell Biol 29: 1303–1310.
- 69. Zhao J, Zhong CJ (2009) A review on research progress of transketolase. Neurosci Bull 25: 94–99.